Table 8. Summary for management of cardiovascular toxicity.
Toxicity | Managemen |
---|---|
Heart failure | Avoid risk factors |
Diuretics, BB, MRA, ACEIs or ARBs | |
CRT or ICD | |
Ischemic heart disease | Nitrate or nitroglycerine |
Antiplatelet agent, anticoagulation | |
BB, CCB, ACEIs or ARBs | |
Lipid-lowering agents | |
Coronary revascularization (intervention or surgery) | |
Hypertension | Diuretics, DHP-CCB, BB, ACEIs or ARBs |
Arrhythmia | |
QT prolongation | Avoid risk factors, ICD in cases of VT or VF |
Atrial fibrillation | Rhythm control: cardioversion |
Rate control: BB, digoxin, non-DHP-CCB | |
Acute pericarditis | Aspirin, NSAID, colchicine |
Pericardial effusion | Pericardiocentesis, pericardiotomy |
Pulmonary arterial hypertension | Ambrisentan, iloprost |
Venous thromboembolism | Anticoagulation |
BB: beta blocker, MRA: mineralocorticoid receptor antagonist, ACEIs: angiotensin converting enzyme inhibitors, ARBs: angiotensin receptor blockers, CRT: cardiac resynchronization therapy, ICD: implantable cardioverter defibrillator, CCB: calcium channel blocker, DHP: dihydropyridine, VT: ventricular tachycardia, VF: ventricular fibrillation, NSAID: nonsteroidal anti-inflammatory drug